Thomas Harris, MD
Foot and Ankle Surgery · Pasadena, CANPI 1801815428
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (45.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 91.9% of it on its own, with 24 other manufacturers making up the rest. Among foot and ankle surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,303 payments — averaging $2329.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2.8M
- Paragon 28, Inc.$195K
- Globus Medical$41K
- Extremity Medical$5K
- Micromed Inc$2K
- Saxum Surgical, Inc.$558
- plus $2K from 19 others
What the payments were for
- Royalty or licence$1,367,77445%
- Consulting fees$280,0839%
- Speaking & faculty fees$1,267,10442%
- Travel & lodging$104,4803%
- Food & beverage$14,3990%
- Education$1,2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1,184 | $2,789,916 |
| Paragon 28, Inc. | 34 | $194,704 |
| Globus Medical | 35 | $40,622 |
| Extremity Medical | 4 | $5,264 |
| Micromed Inc | 6 | $1,870 |
| Saxum Surgical, Inc. | 7 | $558 |
| DNE LLC | 1 | $439 |
| Integra Lifesciences Corporation | 6 | $416 |
| Smith+Nephew | 5 | $202 |
| Trilliant Surgical LLC. | 1 | $149 |
| Medartis Inc. | 1 | $146 |
| Zimmer Biomet | 2 | $144 |
| Stryker | 1 | $126 |
| Bioventus LLC | 2 | $122 |
| Medinc Of Texas | 1 | $79 |
| Medline Industries LP | 3 | $60 |
| Sequoia Surgical, Inc. | 1 | $36 |
| Medshape, Inc. | 1 | $29 |
| Empire Medical, Inc | 1 | $29 |
| Vertex | 1 | $27 |
| Arthrosurface Incorporated | 2 | $27 |
| Misonix Inc | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $24 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$3,956,867
- DISTAL EXTREMITIES IMPLANTS DYNANITE STAPLES$271,923
- DISTAL EXTREMITIES IMPLANTS MIDFOOT PLATES & SCREWS MIDFOOT FRACTURE$270,183
- Product Portfolio$79,887
- Portfolio$57,351
- DISTAL EXTREMITIES IMPLANTS TRAUMA MIDFOOT FRACTURE$56,560
- DISTAL EXTREMITIES IMPLANTS FOOT & ANKLE DYNANITE STAPLES$56,560
- Anthem$17,374
- Small Frag Plating System$11,161
- Ankle Fracture System$7,705
- DISTAL EXTREMITIES IMPLANTS IB LIGAMENT AUGMENTATION OTHER$4,565
- SMALL FRAGMENT$4,056
- BIOLOGICS CONSUMABLES SOFT TISSUE REPAIR ARTHROFLEX$3,480
- DISTAL EXTREMITIES IMPLANTS ANCHORS PUSHLOCKS$2,175
- DISTAL EXTREMITIES IMPLANTS FOREFOOT MTP$2,175
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$1,500
- BIOLOGICS CONSUMABLES CARTILAGE REPAIR CARTILAGE$1,305
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS BONE MARROW$1,305
- BIOLOGICS CONSUMABLES BONE REPAIR BONE GRAFT$1,305
- DISTAL EXTREMITIES IMPLANTS ANCHORS SUTURETAKS & FASTAKS$900
How this compares
$3,035,040 in reported general payments places this provider in the 95th percentile of 1,126 foot and ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $8,093 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 128 | $1,523 |
| Celecoxib | 22 | $969 |
| Gabapentin | 89 | $849 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 84 | $729 |
| Pregabalin | 15 | $426 |
| Tramadol Hcl | 72 | $217 |
| Methylprednisolone | 28 | $163 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $155 |
| Doxycycline Hyclate | 11 | $102 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $47 |
| Timolol Maleate | 11 | $38 |
| Ibuprofen | 25 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Pasadena
- Eric GizaSacramento$3.6M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
- Eric TanLos Angeles$447K
- Joseph ParkBurbank$387K
- Ben WehrliPalm Desert$384K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.